| Website | ziarcopharma.com |
| Category | BioTech |
| contact@ziarcopha... | |
| Employees | |
| Description | Clinical stage biotechnology company |
| TOTAL | $6M |
| FUNDING TOTAL | $6M |
| Series A, 11/12 Biotechnology Value Fund Pfizer Venture Investments | $6M |
Ziarco is an independent, clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery. Ziarco has 4 major development programmes staffed by highly experienced drug development professionals.
